News About: Pharm. Industry
LG Life Sciences picked for Gemiglo
Three Korean drug makers, such as LG Life Sciences (LGLS), Medipost and Ahngook Pharmaceutical, earned awards for their new drugs (Gemiglo, Cartistem and Synatura), while Chong Kun Dang Pharmaceutical and Seoul Pharma...
SK seeks overseas expansion
SK Chemicals, Korea’s leading pharmaceutical and chemical products manufacturer, is ramping up its overseas expansion drive, with the aim of becoming a leading global drug firm.
The company has started construction...
Exforge copycats to hit markets
The patent for Novartis’s Exforge, a drug with two most important ingredients for the treatment of hypertension, is set to expire early April in Korea so a swarm of generic versions can hit the market.
The release ...
KPMA, KoreaBio to cooperate
Cooperation between the Korea Pharmaceutical Manufacturers Association (KPMA) and Korea Biotechnology Industry Organization (KBIO) is picking up, with efforts being made to step up exchanges in the areas of mutual dev...
KPMA vows to stem predatory pricing in hospital biddings
The Korea Pharmaceutical Manufacturers Association (KPMA) on Tuesday vowed to stem the long-standing drug dumpling practice in hospital bidding sector and set the market order straight.
To this end, the KPMA sent ...
KRPIA names new vice chairmenPaul Henry Huibers, CEO of Eli Lilly Korea, was elected this week as vice chairmen of the Korean Research-based Pharmaceutical Industry Association, one of the largest organizat...
|
Dong-A to face criminal suit
A criminal court in Seoul will scrutinize seven former and incumbent of Dong-A Pharmaceutical Co. and two agencies on March 12 on charges of offering kickbacks to doctors and hospital officials.
Earlier last month,...
Local drug makers urged to seek generic drug exclusivity
Under the Korea-US free trade agreement (KORUS FTA), which came into effect last March, Korea has to introduce so called approval-patent linkage system. Relevant articles of the KORUS FTA prescribes that Korea has to ...
Listed drug firms likely to cut dividend payouts on worst profits
Korean pharmaceutical listed firms are considering slashing their cash dividends to be paid out to their shareholders this year as most of their operating profits and net incomes tumbled by more than 10 percent last y...
Expired drugs headache for wholesalers
Local drug wholesalers have found it increasingly difficult to deal with expired medicines co-marketed by foreign and domestic drug firms.
Wholesalers say the problem has surfaced since the co-promotion of medicine...
